We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CEM Signs Exclusive Licensing Agreement with SpheriTech

News   Feb 28, 2014

 
CEM Signs Exclusive Licensing Agreement with SpheriTech
 
 
 

RELATED ARTICLES

Will a Next-generation Therapy for Diabetes Soon Be Available?

News

In order to improve diabetes therapy, researchers at the University of Geneva (UNIGE), Switzerland, have identified a protein called S100A9 which, under certain conditions, seems to act as a blood sugar and lipid regulator while avoiding the most harmful side effects of insulin.

READ MORE

Viagra – The Little Blue Pill Could Reshape Bone Marrow Transplants

News

A study published today in the journal Stem Cell Reports suggests that a combination of two clinically approved drugs – Viagra and Plerixafor – efficiently and rapidly mobilizes blood stem cells from the bone marrow into the bloodstream in a mouse model. This combination therapy may offer a new approach for bone marrow transplants in humans.

READ MORE

“Express Courier Service” for DNA Delivery Expected to Boost Cancer Immunotherapy

News

Immunotherapy is a promising cancer treatment that uses genetically modified immune cells to fight cancer. However, the process known as transfection to generate genetically engineered immune cells in the laboratory has poor efficiency and may have serious side effects. Now, a research team has successfully invented a novel transfection method to deliver DNA into immune cells with minimal stress on these cells.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE